Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes

Gabriele Piuri,Monica Zocchi,Matteo Della Porta,Valentina Ficara,Michele Manoni,Gian Vincenzo Zuccotti,Luciano Pinotti,Jeanette A. Maier,Roberta Cazzola
DOI: https://doi.org/10.3390/nu13020320
IF: 5.9
2021-01-22
Nutrients
Abstract:Magnesium (Mg2+) deficiency is probably the most underestimated electrolyte imbalance in Western countries. It is frequent in obese patients, subjects with type-2 diabetes and metabolic syndrome, both in adulthood and in childhood. This narrative review aims to offer insights into the pathophysiological mechanisms linking Mg2+ deficiency with obesity and the risk of developing metabolic syndrome and type 2 diabetes. Literature highlights critical issues about the treatment of Mg2+ deficiency, such as the lack of a clear definition of Mg2+ nutritional status, the use of different Mg2+ salts and dosage and the different duration of the Mg2+ supplementation. Despite the lack of agreement, an appropriate dietary pattern, including the right intake of Mg2+, improves metabolic syndrome by reducing blood pressure, hyperglycemia, and hypertriglyceridemia. This occurs through the modulation of gene expression and proteomic profile as well as through a positive influence on the composition of the intestinal microbiota and the metabolism of vitamins B1 and D.
nutrition & dietetics
What problem does this paper attempt to address?